Telomir Pharmaceuticals, Inc.'s total assets for Q4 2025 were $7.34M, a decrease of -0.82% from the previous quarter. TELO total liabilities were $1.43M for the fiscal quarter, a 237.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.